3d ex vivo imaging Tumor spheroids

Can spheroid imaging really be this simple?

Now you can perform high-throughput, non-invasive & high-speed  imaging with excellent accuracy 

Discover

3D ex vivo imaging A high-throughput, high-resolution imager for multi-fluorescence imaging of 3D and 2D cultured cells.

SCREEN technology is applicable for various applications such as, skin irritation tests (Cosmetic industry), angiogenesis for monitoring vasculature formation and evaluating antiangiogenic molecules (ex vivo assays), drug screening, efficacy and profiling, neurite outgrowth assays and many more...

Cell3iMager Estier
3D Live -Cell Imaging using Infra red laser Tomography

Read more info

Cell3iMager Neo
High speed and bright-field 3D spheroid imaging system

Read more info

Cell3iMager Duos 2
A high-throughput, high-resolution imager for multi-fluorescence imaging of 3D and 2D cell culture.

Read more info

Forthcoming Event

11th World Congress on Alternatives and Animal Use in the Life Sciences

Maastricht/Virtual meeting

August 25 - 26, 2021

You are invited to visit our booth and speak to our coleagues virtually to get more insight into our technology. 

View event

The female mammary epithelium undergoes reorganization during development, pregnancy, and menopause, linking higher risk with breast cancer development. To characterize these periods of complex remodeling, here we report integrated 50 K mouse and 24 K human mammary epithelial cell atlases obtained by single-cell RNA sequencing, which covers most lifetime stages. Our results indicate a putative trajectory that originates from embryonic mammary stem cells which differentiates into three epithelial lineages (basal, luminal hormone- sensing, and luminal alveolar), presumably arising from unipotent progenitors in postnatal glands. The lineage-specific genes infer cells of origin of breast cancer using The Cancer Genome Atlas data and single-cell RNA sequencing of human breast cancer, as well as the association of gland reorganization to different breast cancer subtypes. This comprehensive mammary cell gene expression atlas (https://mouse-mammary-epitheliumintegrated.cells.ucsc.edu) presents insights into the impact of the internal and external stimuli on the mammary epithelium at an advanced resolution.

 

Read article

SCREEN technology covers wide range of applications from 2D in vitro to 3D ex vivo formats
3D ex vivo imaging

The SCREEN Group traces its history back 150 years to Ishida Kyokuzan Printing Works, a lithographic printing shop founded in Kyoto in 1868. In 1934, we succeeded in producing Japan’s first photographic glass screens, eventually leading to our R&D division being spun off as an independent venture company in 1943 to become Dainippon Screen Mfg. Co., Ltd. Our corporate name actually originated with those first glass screens.

Through the years, the SCREEN Group has continued to meet the rapidly changing needs of various fields, including the electronics industry, particularly in the semiconductor and display markets, and the printing industry, our foundational business area. Our cutting-edge solutions have also enabled us to open up a range of innovative new areas. From our humble origins, we have grown steadily to become a global enterprise with numerous products that hold top shares in their respective markets.

 

Discover Screen

Contact Us!

I agree to the terms and conditions

I agree to the GDPR

Need help finding the right product?
Get in touch
+1 (844) 454-3399